Jade Biosciences, Inc.

Market Cap

$918M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$16.94+$2.78 (+19.63%)

Jun 5, 2026

52W High $26.8552W Low $6.76

Company Details

Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to block the A PRoliferat...

CEO

—

IPO Date

Jun 30, 2021

Website

jadebiosciences.com

Key Metrics TTM

Revenue

- YoY

Net Income

-$130M

EPS (Diluted)

Free Cash Flow

-$117M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q2 2026

Aug 13, 2026

PENDING

Q1 2026

May 7, 2026

FY 2025

Dec 31, 2025

Q4 2025

Dec 31, 2025

Q3 2025

Nov 12, 2025

Revenue & Profitability

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee